Show simple item record

dc.contributor.authorCole, M
dc.date.accessioned2017-03-13T15:04:27Z
dc.date.issued2013-06-01
dc.identifier.citationVol. 34, Iss. 5, pp. 227 - 232en_GB
dc.identifier.urihttp://hdl.handle.net/10871/26524
dc.language.isoenen_GB
dc.publisherSweet and Maxwellen_GB
dc.rights© 2013 Sweet & Maxwell and its Contributorsen_GB
dc.subjectAbuse of dominant positionen_GB
dc.subjectEU lawen_GB
dc.subjectGeneric medicinesen_GB
dc.subjectMarket definitionen_GB
dc.subjectPatentsen_GB
dc.subjectPharmaceutical industryen_GB
dc.subjectSupplementary protection certificatesen_GB
dc.titlePharmaceuticals and competition: first strike to the Commission?en_GB
dc.typeArticleen_GB
dc.date.available2017-03-13T15:04:27Z
dc.identifier.issn0144-3054
dc.descriptionThis is the author accepted manuscript. The final version is available from Sweet and Maxwell via the DOI in this record.en_GB
dc.identifier.journalECLR: European Competition Law Reviewen_GB
refterms.dateFOA2023-10-03T18:01:36Z


Files in this item

This item appears in the following Collection(s)

Show simple item record